Successful Industry Collaboration Leads to Another Collective Victory: WMIS Launches Clinical Trials

Trial is Critical for PET Reimbursement With the success of the World Molecular Imaging Society's (WMIS) initiative in helping obtain the FDA approval for Sodium Fluoride F18 injection, WMIS is now launching critical clinical trials to secure fair and meaningful reimbursement for this procedure. Successful clinical trials for reimbursement are necessary to ensure the feasibility and market acceptance for this diagnostic test. Herndon, VA (PRWEB) November 30, 2011 With the success of the World Molecular Imaging Society's (WMIS) initiative in helping obtain the FDA approval for Sodiu
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations